However, in all cases reduction of EZH2 by miRNAs inhibited tumor growth and metastasis in mouse models, suggesting that these miRNAs act as tumor and metastasis suppressors, and demonstrate that EZH2 is an important therapeutic target in breast cancer. The gene discussed is EZH2; the disease is neoplasm.